Why only some teens develop cognitive problems from cannabis: a genetic vulnerability in brain support cells
In mice, adolescent THC exposure only impaired adult memory when combined with a genetic vulnerability in astrocytes (brain support cells), operating through an inflammatory pathway that could be blocked by a COX-2 inhibitor.
Quick Facts
What This Study Found
Astrocyte-specific expression of DN-DISC1 combined with adolescent THC synergistically impaired recognition memory in adult mice. The mechanism involved NF-kB-COX-2 inflammatory pathway activation in astrocytes and decreased parvalbumin-positive inhibitory connections in the hippocampus. A COX-2 inhibitor (NS398) prevented the cognitive deficits.
Key Numbers
DN-DISC1 in astrocytes + adolescent THC: synergistic memory impairment. Mechanism: NF-kB-COX-2 pathway activation in astrocytes. Decreased parvalbumin-positive boutons around hippocampal CA3 pyramidal neurons. COX-2 inhibitor NS398 prevented cognitive deficits.
How They Did This
Transgenic mice with inducible dominant-negative DISC1 expression selectively in astrocytes were treated with THC during adolescence. Adult recognition memory was tested. Molecular pathways examined included NF-kB-COX-2 signaling and hippocampal parvalbumin interneuron connectivity.
Why This Research Matters
This answers a critical question: why do some adolescent cannabis users develop lasting cognitive problems while others don't? Genetic vulnerability in astrocytes, not neurons, determined whether THC caused lasting harm, and the inflammatory mechanism is potentially treatable.
The Bigger Picture
The fact that astrocyte (not neuron) genetics determined vulnerability to THC is paradigm-shifting. Most cannabis-brain research has focused on neurons, but this study shows support cells are the gatekeepers of whether cannabis causes lasting damage. The COX-2 inhibitor finding offers a potential protective intervention.
What This Study Doesn't Tell Us
Transgenic mouse model with artificial DISC1 disruption. Single memory test (recognition memory). The DISC1 gene's role in human schizophrenia risk is debated. COX-2 inhibition has its own side effects that limit clinical translation.
Questions This Raises
- ?Could astrocyte-based genetic screening identify at-risk adolescents?
- ?Would low-dose COX-2 inhibitors protect vulnerable teens who use cannabis?
- ?Do other astrocyte genes similarly modulate cannabis vulnerability?
Trust & Context
- Key Stat:
- Astrocyte genetic vulnerability + adolescent THC = lasting memory impairment, preventable with COX-2 inhibitor
- Evidence Grade:
- Preliminary: sophisticated transgenic mouse study published in Biological Psychiatry with clear mechanism, but animal model.
- Study Age:
- Published in 2019 in Biological Psychiatry.
- Original Title:
- Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.
- Published In:
- Biological psychiatry, 85(11), 891-903 (2019)
- Authors:
- Jouroukhin, Yan(2), Zhu, Xiaolei(3), Shevelkin, Alexey V, Hasegawa, Yuto, Abazyan, Bagrat, Saito, Atsushi, Pevsner, Jonathan, Kamiya, Atsushi, Pletnikov, Mikhail V
- Database ID:
- RTHC-02093
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why does cannabis affect some teens' memory but not others?
This study found the answer lies in astrocytes (brain support cells). Mice with a genetic vulnerability in astrocytes developed lasting memory problems from adolescent THC, while those without the vulnerability did not.
Could this vulnerability be prevented?
In mice, a COX-2 inhibitor (an anti-inflammatory drug) completely prevented the THC-induced cognitive impairment in genetically vulnerable animals. This suggests the inflammatory pathway in astrocytes is the critical link that could potentially be blocked.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-02093APA
Jouroukhin, Yan; Zhu, Xiaolei; Shevelkin, Alexey V; Hasegawa, Yuto; Abazyan, Bagrat; Saito, Atsushi; Pevsner, Jonathan; Kamiya, Atsushi; Pletnikov, Mikhail V. (2019). Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.. Biological psychiatry, 85(11), 891-903. https://doi.org/10.1016/j.biopsych.2018.07.024
MLA
Jouroukhin, Yan, et al. "Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.." Biological psychiatry, 2019. https://doi.org/10.1016/j.biopsych.2018.07.024
RethinkTHC
RethinkTHC Research Database. "Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Sp..." RTHC-02093. Retrieved from https://rethinkthc.com/research/jouroukhin-2019-adolescent-9tetrahydrocannabinol-exposure-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.